Story
Hims & Hers Stock Surges on FDA Panel's BPC-157 Recommendation

Shares of Hims & Hers Health, Inc. (NYSE: HIMS) surged in Thursday trading after a U.S. Food and Drug Administration advisory committee recommended expanding access to the peptide compound BPC-157. The development sparked investor optimism about a potential new product category for the telehealth platform.
Market Reaction
The company's stock climbed approximately 11% during Thursday's midday session, according to a report from Investing.com. The significant intraday gain reflects positive market sentiment regarding the potential commercial opportunities that could arise from the committee's recommendation.
The Regulatory Catalyst
The primary driver for the stock's advance was the positive recommendation from an FDA advisory panel concerning the peptide BPC-157. Peptides like BPC-157 have gained attention for their potential therapeutic properties, but their regulatory pathways can be complex.
AdWhile a committee recommendation is not a final decision by the FDA, it is a crucial step that can influence the agency's ultimate ruling on a compound's availability. An expansion of access could move the peptide from a regulatory gray area into a more mainstream, accessible market.
Implications for Hims & Hers
Hims & Hers operates a direct-to-consumer telehealth platform that provides prescription and over-the-counter treatments for various health and wellness conditions. Investors may be speculating that if the FDA follows the committee's advice, the company is well-positioned to add BPC-157-based treatments to its portfolio.
Such a move could open up a significant new revenue stream in the popular wellness and recovery market, leveraging the company's established distribution and subscription model to reach a broad consumer base.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.